EN
HI
Sudeep Pharma Share Price
SUDEEPPHRM
1199.26.30 (-0.52%)
NSE
BSE
Free Demat with Zero AMC*
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
Summary
As of 15 Nov, 2026, Sudeep Pharma stock price is ₹1199.2. During the trading session, the stock has moved between an intraday low of ₹1188.50 and an intraday high of ₹1219.80. Over the last 52 weeks, Sudeep Pharma has traded between ₹524.05 and ₹1378.00.
The stock has recorded a trading volume of 1,00,818 shares,. Its Average Traded Price (ATP) is ₹1201.64, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 2 @ ₹1199.20.
Sudeep Pharma has an upper circuit limit of ₹1319.10 and a lower circuit limit of ₹1079.30. The total value traded stands at ₹12.11 CR, and the delivery percentage for the day is 45.17%.
The stock is currently traded with a market lot size of 1. Sudeep Pharma also offers a dividend yield of 0.13%.
Sudeep Pharma Share Price Chart
Sudeep Pharma Share Key Metrics
Volume
1.01 L
Market Cap
13544.80 CR
LTQ@LTP
2@1199.20
ATP
1201.64
Var Margin
20.16 %
Circuit Range
1079.3-1319.1
Delivery %
45.17 %
Value
12.11 CR
ASM/GSM
No
Market Lot
1
Sudeep Pharma Resistance and Support
Pivot 1220.9
Resistance
First Resistance
1241.9
Second Resistance
1278.3
Third Resistance
1299.3
Support
First Support
1184.5
Second Support
1163.5
Third Support
1127.1
Sudeep Pharma Shareholding Pattern
View More- 2023-24
- 2024-25
- 2025-26
- 2026-27
Total Promoters
Segment
Percent
Total Promoters
76.15%
Mutual Fund
7.43%
Insurance
1.02%
Foreign Institutional Investors
2.93%
Domestic Institutional Investors
5.6%
Retail
6.87%
Others
0%
Total Promoters
MAR '26
76.15%
JUN '26
76.15%
SEP '26
76.15%
Sudeep Pharma Corporate Actions
| Date | Agenda |
|---|---|
| 2026-10-28 | Quarterly Results |
| 2026-08-04 | Quarterly Results |
| 2026-05-21 | Audited Results |
| 2026-02-06 | Quarterly Results |
| 2025-12-19 | Quarterly Results |
| Ex Date | Record Date | |
|---|---|---|
| 2026-07-23 | 2026-07-23 | View More |
Sudeep Pharma News
Sudeep Pharma Ltd - 544619 - Board Meeting Outcome for Outcome Of Board Meeting Held On 28Th October 2026
Sudeep Pharma reported Q2 FY27 cons. revenue of ₹196.70 crores, up 20.9% YoY, and a net profit of ₹51.81 crores, a 10.8% YoY growth. Unutilized IPO net proceeds of ₹55.81 crores remain in bank term deposits pending capital expenditure deployment.
Oct 28 2026 16:47:35
Sudeep Pharma Ltd - 544619 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Sudeep Pharma received FDA approval to commence operations at its new 51,200 MT greenfield manufacturing facility in Nandesari, Gujarat. Commercial supplies are expected to begin in H2 FY27.
Oct 26 2026 12:31:37
Sudeep Pharma Ltd - 544619 - Board Meeting Intimation for Adoption And Approval Of Un-Audited Financial Results (Standalone & Consolidated) For The Quarter And Half Year Ended 30Th September 2026
Sudeep Pharma board to meet on 28 Oct 2026 for financial results.
Oct 21 2026 11:30:24
Read More
Sudeep Pharma Management
| Name | Position |
|---|---|
| Sujit Jaysukh Bhayani | Chairman & Managing Director |
| Shanil Sujit Bhayani | Whole Time Director |
Sudeep Pharma Similar Stocks
Molbio Diagnostics Ltd.
1493.20
99.10 (7.11%)
Vijaya Diagnostic Centre Ltd.
1410.10
-5.50 (0.39%)
CORONA Remedies Ltd.
2329.70
-12.50 (0.53%)
Marksans Pharma Ltd.
318.50
-1.50 (0.47%)
Rainbow Children's Medicare Ltd.
1271.50
-21.20 (1.64%)
Alivus Life Sciences Ltd.
1460.60
16.90 (1.17%)
Concord Biotech Ltd.
594.00
-7.80 (1.30%)
Akums Drugs & Pharmaceuticals Ltd.
741.05
-8.85 (1.18%)
Metropolis Healthcare Ltd.
564.20
-1.00 (0.18%)
Sudeep Pharma FAQs
The Buying Price of Sudeep Pharma share is 1199.2 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Sudeep Pharma stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Sudeep Pharma, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Sudeep Pharma shares is 71.89. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Sudeep Pharma shares is 14.14. Useful to assess the stock's value relative to its book value.
To assess Sudeep Pharma’s valuation compare Sector P/E, P/B which are 41.18 & 2.49 with sector averages, along with growth rates and financial metrics.
The Market Cap of Sudeep Pharma is 13544.80 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Sudeep Pharma share price is 1378.00 & 524.05. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Sudeep Pharma belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year
Auto Square Off Charges
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools

Open Your Free
Demat Account Now!
AMC For First Year
Account Opening Fee
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools
Invest in SUDEEPPHRM
Account Opening Fee AMC for 1st Year Auto Square Off Charges Call & Trade
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
Or Download Choice FinX App
Invest in SUDEEPPHRM
Account Opening Fee AMC for 1st Year Auto Square Off Charges Call & Trade